Gratwohl A, Brand R, Mcgrath E, Van Biezen A, Sureda A, Ljungman P, et al. Clinical program standards: quality management 2021. International standards for hematopoietic cellular therapy product collection, processing, and administration. 2006 354:1813–26.įoundation for the accreditation of cellular therapy (FACT), Joint accreditation committee - ISCT and EBMT (JACIE). The tool is extensible to be able to accommodate future changes in outcome review and center-specific extensions.Ĭopelan EA. The current work demonstrates that using registry data, standardized tools can be made to analyze this data, which allows users to perform outcome reviews for local and accreditation purposes graphically with minimal effort, and help perform detailed standardized analyses. We show the use of this tool on a two-year single-center pediatric cohort, demonstrating how the results for both overall and event-free survival and engraftment can be visualized. YORT allows users to export data as analyzed to allow you to check data and perform manual analyses. To achieve this, we created the Yearly Outcome Review Tool (YORT), an offline, graphical tool that gets data from a single center EBMT registry export, allows the user to define filters and groups, and performs standardized analyses for overall survival, event-free survival, engraftment, relapse rate and non-relapse mortality, complications including acute and chronic Graft vs Host Disease (GvHD), and data completeness. When data has been entered in a standardized registry, outcome analyses can be automated, which reduces work and increases standardization of performed analyses. Auditing and yearly outcome reviews help keep optimal quality of care and come with increased survival, but also has significant recurring costs. Hematopoietic stem cell transplantation is a high-risk procedure.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |